Table 1 Epidemiological and clinical characteristics of each patient pooled.
Patients characteristics | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
|---|---|---|---|---|
Gender | Female | Male | Female | Male |
Age (years) | 52 | 47 | 54 | 53 |
Ethnic group | Caucasian | Caucasian | Caucasian | Caucasian |
HIV infection | HIV-1 | HIV-1 | HIV-1 | HIV-1 |
Route of transmission | IDUs | Sexual | IDUs | IDUs |
Viral subtype | Unknown | B | Unknown | Unknown |
HIV viral load (Ul/ml) | Undetectable | < 20 | < 40 | Undetectable |
Clinical stage | B3 | A1 | B3 | B3 |
Antiretroviral therapy | ABC/DTG/3TC | ABC/DTG/3TC | 3TC + DRV/c | ETR + DRV/r |
Viral tropism | No | No | No | No |
CD4 (%) | 26 | 36 | 30 | 29 |
Chronic HCV infection | Yes | Yes | Yes | Yes |
HCV route of transmission | IDUs | Sexual | IDUs | IDUs |
Genotype and viral subtype | 1a | 1a | 1 | 4 |
HCV active infection | Yes | Yes | Yes | Yes |
HCV viral load (Ul/ml) | 786,000 | 353,000 | 74,300 | 10,000,000 |
Fibrosis stage | F0–F1 | Unknown | F0–F1 | F0–F1 |
Fibroscan | 6 | – | 4,3 | 5,2 |
Coinfected with cytomegalovirus | Yes | Yes | No | Yes |
Hepatitis B | Resolved | Resolved | Resolved | Vaccinated |
